Intra-voxel incoherent motion MRI in rodent model of diethylnitrosamine-induced liver fibrosis

Magnetic Resonance Imaging

Volumn 31, Issue 6, 2013, Pages 1017-1021

  Zhang, Yue ^a,b   Jin, Ning ^c   Deng, Jie ^d   Guo, Yang ^b   White, Sarah B ^b,e   Yang, Guang Yu ^b   Omary, Reed A ^b,f   Larson, Andrew C ^a,b,f  

^a University of Illinois at Chicago   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Siemens Healthcare   (United States)

^d CHILDREN'S MEMORIAL HOSPITAL   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f Northwestern University   (United States)

Author keywords

Diffusion weighted MRI; Intra Voxel Incoherent Motion; Liver fibrosis

Indexed keywords

DIETHYLNITROSAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSION; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; IMAGE ANALYSIS; IMAGE QUALITY; INTRA VOXEL INCOHERENT MOTION; LIVER FIBROSIS; LIVER PERFUSION; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; STAINING;

ANIMALS; ARTIFACTS; DIETHYLNITROSAMINE; DISEASE MODELS, ANIMAL; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MALE; MOVEMENT; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

ANIMALIA; RATTUS; RODENTIA;

EID: 84878663123     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2013.03.007     Document Type: Article

References (34)

1. Schuppan D., Popov Y. Hepatic fibrosis: from bench to bedside. J Gastroenterol Hepatol 2002, 17(Suppl 3):S300-S305.
2. Friedman S.L. Liver fibrosis - from bench to bedside. J Hepatol 2003, 38(Suppl 1):S38-S53.
3. Williams R. Global challenges in liver disease. Hepatology (Baltimore, Md) 2006, 44(3):521-526.
4. Proceedings of the European Association for the Study of the Liver (EASL) International Consensus Conference on Hepatitis B. September 14-16, 2002. Geneva, Switzerland. J Hepatol 2003, 39(Suppl 1):S1-S235.
5. Poynard T., Bedossa P., Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997, 349(9055):825-832.
6. Dienstag J.L. The role of liver biopsy in chronic hepatitis C. Hepatology (Baltimore, Md) 2002, 36(5 Suppl 1):S152-S160.
7. Afdhal N.H., Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 2004, 99(6):1160-1174.
8. Aube C., Racineux P.X., Lebigot J., et al. Diagnosis and quantification of hepatic fibrosis with diffusion weighted MR imaging: preliminary results. J Radiol 2004, 85(3):301-306.
9. Lewin M., Poujol-Robert A., Boelle P.Y., et al. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology (Baltimore, Md) 2007, 46(3):658-665.
10. Le Bihan D., Breton E., Lallemand D., Aubin M.L., Vignaud J., Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988, 168(2):497-505.
11. Turner R., Le Bihan D., Maier J., Vavrek R., Hedges L.K., Pekar J. Echo-planar imaging of intravoxel incoherent motion. Radiology 1990, 177(2):407-414.
12. Le Bihan D., Breton E., Lallemand D., Grenier P., Cabanis E., Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986, 161(2):401-407.
13. Annet L., Materne R., Danse E., Jamart J., Horsmans Y., Van Beers B.E. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 2003, 229(2):409-414.
14. Luciani A., Vignaud A., Cavet M., et al. Liver cirrhosis: intravoxel incoherent motion MR imaging-pilot study. Radiology 2008, 249(3):891-899.
15. Annet L., Peeters F., Abarca-Quinones J., Leclercq I., Moulin P., Van Beers B.E. Assessment of diffusion-weighted MR imaging in liver fibrosis. J Magn Reson Imaging 2007, 25(1):122-128.
16. Yamada I., Aung W., Himeno Y., Nakagawa T., Shibuya H. Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 1999, 210(3):617-623.
17. Girometti R., Furlan A., Esposito G., et al. Relevance of b-values in evaluating liver fibrosis: a study in healthy and cirrhotic subjects using two single-shot spin-echo echo-planar diffusion-weighted sequences. J Magn Reson Imaging 2008, 28(2):411-419.
18. Steinhoff D. Effect of diethylnitrosamine on the livers of rats after high oral doses administered at intervals varying between three and twenty-four days. Acta Hepatogastroenterol (Stuttg). 1975, 22(2):72-77.
19. Patel J., Sigmund E.E., Rusinek H., Oei M., Babb J.S., Taouli B. Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging 2010, 31(3):589-600.
20. Vyvenko O.F. Exponential analysis in physical phenomena. Rev Sci Instrum 1999, 70(2):25p.
21. Yao L., Sinha U. Imaging the microcirculatory proton fraction of muscle with diffusion-weighted echo-planar imaging. Acad Radiol 2000, 7(1):27-32.
22. Wirestam R., Borg M., Brockstedt S., Lindgren A., Holtas S., Stahlberg F. Perfusion-related parameters in intravoxel incoherent motion MR imaging compared with CBV and CBF measured by dynamic susceptibility-contrast MR technique. Acta Radiol 2001, 42(2):123-128.
23. Callot V., Bennett E., Decking U.K., Balaban R.S., Wen H. In vivo study of microcirculation in canine myocardium using the IVIM method. Magn Reson Med 2003, 50(3):531-540.
24. Muskopf S. Rat dissection step 6 Available at:, Accessed. http://www.biologycorner.com/worksheets/rat_dissection06.html.
25. Masseroli M., Caballero T., O'Valle F., Del Moral R.M., Perez-Milena A., Del Moral R.G. Automatic quantification of liver fibrosis: design and validation of a new image analysis method: comparison with semi-quantitative indexes of fibrosis. J Hepatol 2000, 32(3):453-464.
26. Wong J.B., Bennett W.G., Koff R.S., Pauker S.G. Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs. JAMA 1998, 280(24):2088-2093.
27. Aube C., Oberti F., Korali N., et al. Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J Hepatol 1999, 30(3):472-478.
28. Sandrin L., Fourquet B., Hasquenoph J.M., et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003, 29(12):1705-1713.
29. Romero-Gomez M., Gomez-Gonzalez E., Madrazo A., et al. Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C. Hepatology (Baltimore, Md.) 2008, 47(3):810-816.
30. Muthupillai R., Ehman R.L. Magnetic resonance elastography. Nat Med 1996, 2(5):601-603.
31. Koinuma M., Ohashi I., Hanafusa K., Shibuya H. Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Magn Reson Imaging 2005, 22(1):80-85.
32. Baxter S., Wang Z.J., Joe B.N., Qayyum A., Taouli B., Yeh B.M. Timing bolus dynamic contrast-enhanced (DCE) MRI assessment of hepatic perfusion: initial experience. J Magn Reson Imaging 2009, 29(6):1317-1322.
33. Barash H., Gross E., Edrei Y., et al. Functional magnetic resonance imaging monitoring of pathological changes in rodent livers during hyperoxia and hypercapnia. Hepatology (Baltimore, Md) 2008, 48(4):1232-1241.
34. Jin N., Deng J., Chadashvili T., et al. Carbogen gas-challenge BOLD MR imaging in a rat model of diethylnitrosamine-induced liver fibrosis. Radiology 2010, 254(1):129-137.